Geneva
'A sensational debut' CLARE MACKINTOSH
-
- 13,99 €
-
- 13,99 €
Description de l’éditeur
*Richard Armitage's second utterly compelling thriller, THE CUT, is out now!*
She can't trust anyone. Not even herself . . .
*Shortlisted for the Fingerprint Award for Debut Book of the Year*
*Shortlisted for the Best Fiction Audiobook at the British Book Awards*
'I raced through it.' Lucy Foley
'Outstanding.' Harlan Coben
'Heart-pounding.' Lucy Clarke
When you have it all
Sarah Collier has been lucky: she's got a glittering scientific career and a husband who loves her more than anything.
And you start to lose it
But now she's showing signs of early Alzheimer's, and the only hope for a cure is in a controversial new technology being unveiled in Switzerland.
You'd go anywhere for help
In Geneva, as events turn dangerous and her memory loss worsens, Sarah has to decide who to trust: the people around her - or, despite her symptoms, herself.
'Sensational.' Clare Mackintosh
'Immensely readable.' Sarah Hilary
'A fast-paced switchback ride.'Daily Mail
'Highly addictive.' Alice Feeney
'A clever page-turner.' The Times
'A rollercoaster ride.'Guardian
'Stunning.' Helen Fields
'Pacy as hell.' Imran Mahmood
'Icily tense.' Telegraph
'Has it all!' L. J. Ross
'Loved it!! Gripping from first page to last, there is no let up!' ⭐⭐⭐⭐⭐ reader review
'Absolutely fantastic debut novel. Intelligent thriller, great twists, strong women . . . Loved it!' ⭐⭐⭐⭐⭐ reader review
'The twists are fast and furious. What an ending. Be still my racing heart!' ⭐⭐⭐⭐⭐ reader review
Shortlisted for Debut Book of the Year for 2023 at the Capital Crime Fingerprint Awards, 2024
Shortlisted for the Best Fiction Audiobook at the British Book Awards, 2023
PUBLISHERS WEEKLY
British scientist Sarah Collier hasn't yet had time to savor her Nobel Prize win when her life skids off course in this propulsive debut from actor Armitage. Already struggling with her widowed father's accelerating Alzheimer's, Sarah begins to experience alarming symptoms herself, including blackouts and memory loss, which she and her neuroscientist spouse, Daniel, fear could herald the same diagnosis. Reeling, Sarah craves nothing more than cocooning with her family—especially her young daughter, Maddie—before the disease takes hold. Then she receives an offer she can't refuse: an invitation to Geneva's prestigious Schiller Institute to be the guest of honor at biotech tycoon Mauritz Schiller's gala launch of Neurocell, a revolutionary neural implant designed to treat memory disorders including Alzheimer's. At the event, Sarah is forced to battle her own failing body as money-hungry scientists and executives hope to grab a piece of the Neurocell pie for themselves. Switching the narration back and forth between the sympathetic Sarah and her more aloof, mysterious husband, Armitage speeds his thriller around a twisty plot as hair-raising as an Olympic luge run. Though a few reveals strain credibility, readers will plow right through them. This promising performance demands an encore.
